Rhea Chakraborty’s father condemns son's arrest by NCB, issues statement: Congratulations India

-

Actor Rhea Chakraborty’s father Indrajit Chakraborty has issued a statement condemning the arrest of his son, Showik, in connection with drug abuse allegations surrounding actor Sushant Singh Rajput’s death.

"Congratulations India, you have arrested my son, I'm sure next on the line is my daughter and I don't know who is next thereafter. You have effectively demolished a middle-class family. But of course, for the sake of justice, everything is justified. Jai Hind," the statement from Lt Col Indrajit Chakraborty (Retd), who has also been questioned by the CBI, read.

A Mumbai court on Saturday, 5 September, remanded Showik and Samuel Miranda, Rajput's house manager, to the custody of the Narcotics Control Bureau (NCB) till 9 September.

Meanwhile, NCB has also issued summons to Rhea for joining probe on Sunday. 6 September.

rhea chakraborty - pti

The NCB earlier took Showik and Miranda to a civic hospital for medical tests on Saturday morning, an official said.

After the tests, the duo were presented in a local court, he said.

They were arrested by the NCB under various sections of the Narcotic Drugs and Psychotropic Substances (NDPS) Act on Friday night after over 10 hours of questioning.

"Both the accused were taken to the civic-run Sion Hospital around 9.15 am on Saturday by an NCB team for formalities of medical tests," the official said.

"After the completion of the process, they will be produced in a court," he added.

The NCB is probing the drug angle in this case under criminal sections of the NDPS Act after the Enforcement Directorate (ED) shared with it a report following the cloning of two mobile phones of Rhea.

A few others have also been arrested by the agency.

Rajput was found dead at his flat in suburban Bandra area on 14 June.

(With inputs from Press Trust of India)



from Firstpost India Latest News https://ift.tt/3i7dkzm
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more